Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-000452
Filing Date
2023-01-03
Accepted
2023-01-03 21:21:35
Documents
1
Period of Report
2022-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5282
  Complete submission text file 0000899243-23-000452.txt   8213
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Disc Medicine, Inc. (Issuer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Opportunity Fund II, L.P. (Reporting) CIK: 0001885327 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39438 | Film No.: 23504173

Mailing Address 300 TECHNOLOGY SQUARE, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE, 8TH FLOOR CAMBRIDGE MA 02139 857 201 2700
Atlas Venture Associates Opportunity II, LLC (Reporting) CIK: 0001935810 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39438 | Film No.: 23504171

Mailing Address 300 TECHNOLOGY SQUARE, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE, 8TH FLOOR CAMBRIDGE MA 02139 1 857 201 2700
Atlas Venture Associates Opportunity II, LP (Reporting) CIK: 0001935814 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39438 | Film No.: 23504172